Classical Macrophage Activation Up-Regulates Several Matrix Metalloproteinases through Mitogen Activated Protein Kinases and Nuclear Factor-κB

Remodelling of the extracellular matrix (ECM) and cell surface by matrix metalloproteinases (MMPs) is an important function of monocytes and macrophages. Recent work has emphasised the diverse roles of classically and alternatively activated macrophages but the consequent regulation of MMPs and their inhibitors has not been studied comprehensively. Classical activation of macrophages derived in vitro from un-fractionated CD16+/− or negatively-selected CD16− macrophages up-regulated MMP-1, -3, -7, -10, -12, -14 and -25 and decreased TIMP-3 steady-state mRNA levels. Bacterial lipopolysaccharide, IL-1 and TNFα were more effective than interferonγ except for the effects on MMP-25, and TIMP-3. By contrast, alternative activation decreased MMP-2, -8 and -19 but increased MMP -11, -12, -25 and TIMP-3 steady-state mRNA levels. Up-regulation of MMPs during classical activation depended on mitogen activated protein kinases, phosphoinositide-3-kinase and inhibitor of κB kinase-2. Effects of interferonγ depended on janus kinase-2. Where investigated, similar effects were seen on protein concentrations and collagenase activity. Moreover, activity of MMP-1 and -10 co-localised with markers of classical activation in human atherosclerotic plaques in vivo. In conclusion, classical macrophage activation selectively up-regulates several MMPs in vitro and in vivo and down-regulates TIMP-3, whereas alternative activation up-regulates a distinct group of MMPs and TIMP-3. The signalling pathways defined here suggest targets for selective modulation of MMP activity.

[1]  A. Newby Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[2]  C. Brinckerhoff,et al.  Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors , 2001, Arthritis Research & Therapy.

[3]  L. Lue,et al.  Gene expression changes by amyloid β peptide‐stimulated human postmortem brain microglia identify activation of multiple inflammatory processes , 2006, Journal of leukocyte biology.

[4]  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. , 2004, The Journal of clinical investigation.

[5]  S. Chakraborti,et al.  Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.

[6]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[7]  D. Edwards,et al.  The regulation of matrix metalloproteinases and their inhibitors. , 2008, The international journal of biochemistry & cell biology.

[8]  M. Duddy,et al.  Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. , 2003, Brain : a journal of neurology.

[9]  D. Mazzatti,et al.  Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium , 2009, Pflügers Archiv - European Journal of Physiology.

[10]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[11]  J. Friedland,et al.  Matrix metalloproteinases in tuberculosis , 2011, European Respiratory Journal.

[12]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[13]  D. Ramji,et al.  Critical Role for Casein Kinase 2 and Phosphoinositide-3-Kinase in the Interferon-&ggr;–Induced Expression of Monocyte Chemoattractant Protein-1 and Other Key Genes Implicated in Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Peter Libby,et al.  Atherosclerosis and proteinase activation. , 2006, Cardiovascular research.

[15]  A. Newby,et al.  Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. , 2005, Physiological reviews.

[16]  Markus S. Mueller,et al.  MMP19 Is Essential for T Cell Development and T Cell-Mediated Cutaneous Immune Responses , 2008, PloS one.

[17]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[18]  P. Libby,et al.  C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. , 2006, Journal of the American College of Cardiology.

[19]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[20]  D. Pei Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage , 1999, Cell Research.

[21]  C. Kaps,et al.  Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study , 2008, Arthritis research & therapy.

[22]  A. Mantovani,et al.  Analysis of the Gene Expression Profile Activated by the CC Chemokine Ligand 5/RANTES and by Lipopolysaccharide in Human Monocytes1 , 2002, The Journal of Immunology.

[23]  J. Foidart,et al.  Matrix metalloproteinase-19 deficiency promotes tenascin-C accumulation and allergen-induced airway inflammation. , 2010, American journal of respiratory cell and molecular biology.

[24]  Silvano Sozzani,et al.  Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.

[25]  A. Baker,et al.  Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. , 1999, Biochemical and biophysical research communications.

[26]  A. Newby,et al.  Role of Nuclear Factor-&kgr;B Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In Vivo , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[27]  W. English,et al.  Matrix metalloproteinases in arthritic disease , 2002, Arthritis research.

[28]  P. Libby,et al.  Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.

[29]  Wei-Chun Huang,et al.  Diverse patterns of cyclooxygenase-independent metalloproteinase gene regulation in human monocytes , 2011, British journal of pharmacology.

[30]  Jeffrey W. Smith,et al.  Inflammatory Proprotein Convertase-Matrix Metalloproteinase Proteolytic Pathway in Antigen-presenting Cells as a Step to Autoimmune Multiple Sclerosis* , 2009, The Journal of Biological Chemistry.

[31]  D. Pei,et al.  Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. , 2004, Experimental Cell Research.

[32]  L. Boscá,et al.  Cot/tpl2 activity is required for TLR‐induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression , 2011, European journal of immunology.

[33]  A. Newby,et al.  Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. , 2001, Cardiovascular research.

[34]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[35]  Anne M Manicone,et al.  Matrix metalloproteinases as modulators of inflammation. , 2008, Seminars in cell & developmental biology.

[36]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[37]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[38]  R. Sedláček,et al.  Matrix Metalloproteinase-19 Is Expressed in Myeloid Cells in an Adhesion-Dependent Manner and Associates with the Cell Surface1 , 2002, The Journal of Immunology.

[39]  Jason L Johnson,et al.  Low Tissue Inhibitor of Metalloproteinases 3 and High Matrix Metalloproteinase 14 Levels Defines a Subpopulation of Highly Invasive Foam-Cell Macrophages , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[40]  W. English,et al.  Membrane-type 1-Matrix Metalloproteinase Regulates Intracellular Adhesion Molecule-1 (ICAM-1)-mediated Monocyte Transmigration* , 2007, Journal of Biological Chemistry.

[41]  T. Salo,et al.  Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation , 2006, Annals of medicine.